EICHOR
● Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
Condition: CLL/SLL · Sponsor: Ascentage Pharma Group Inc.
About this study
This is a global multicenter, open label, randomized, registrational phase III study to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients who previously treated with BTK inhibitors
This description comes directly from the study's public registry record.
Talk to the study team
Shanthi Marur, MD · 3017925062 · shanthi.marur@ascentage.com
Yifan Zhai, MD · 301-549-6188 · yzhai@ascentage.com
Always discuss trial participation with your own doctor first.
Locations (135)
| Ascentage Investigative Site | Tuscon, Arizona, United States | Recruiting |
| Ascentage Investigative Site | Anaheim, California, United States | Recruiting |
| Ascentage Investigative Site | Jacksonville, Florida, United States | Recruiting |
| Ascentage Investigative Site | Miami Beach, Florida, United States | Recruiting |
| Ascentage Investigative Site | Peoria, Illinois, United States | Recruiting |
| Ascentage Investigative Site | Boston, Massachusetts, United States | Recruiting |
| Ascentage Investigative Site | Ann Arbor, Michigan, United States | Recruiting |
| Ascentage Investigative Site | Greenville, North Carolina, United States | Recruiting |
| Ascentage Investigative Site | Houston, Texas, United States | Recruiting |
| Ascentage Investigative Site | Kingswood, Texas, United States | Recruiting |
| Ascentage Investigative Site | Richmond, Virginia, United States | Recruiting |
| Ascentage Investigative Site | Gosford, Australia | Completed |
+ 123 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06104566